NT5E and hepatocellular carcinoma: Intriguingly, CD73 is also critical for promoting other multiple kinase inhibitor resistance, such as sorafenib or Cabozantinib (Additional file 8: Figure S6), which suggests the potential role of CD73 in sustaining multiple kinase resistance of HCC, and more investigations are needed to confirm our findings.